Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Heterocyclic compound useful as a modulator of ATP-binding cassette transporters.
No-Receipt date
2016-01355 - 18/05/2016
No-Filing date
20160800018 - 18/05/2016
No-Granting date
8000647 - 22/01/2018
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
9/2016 - 20/10/2016
Gazette No-Publication date of granted patent
1/2018 - 30/03/2018
Expiration date
25/11/2030
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
US734506 P08/11/2005/US
US754086 P27/12/2005/US
US802458 P22/05/2006/US
Active Substance of Supplementary Certificates
3-{6-{[1-(2,2-ΔΙΦΘΟΡΟ-1,3-ΒΕΝΖΟΔΙΟΞΟΛ-5-ΥΛ)ΚΥΚΛΟΠΡΟΠΑΝΟΚΑΡΒΟΝΥΛ]ΑΜΙΝΟ}-3-ΜΕΘΥΛΠΥΡΙΔΙΝ-2-ΥΛ}ΒΕΝΖΟΪΚΟ ΟΞΥ, Ή ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΟ ΑΛΑΣ ΑΥΤΟΥ, Ή ΕΣΤΕΡΑΣ ΑΥΤΟΥ
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20130402149
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
692512
VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
MA 02210, BOSTON U.S.A.
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1198710
HADIDDA RUAH, SARA
1198711
HAMILTON, MATTHEW
1198712
MILLER, MARK
1198713
GROOTENHUIS, PETER, D., J.
1198714
BEAR, BRIAN
1198715
MCCARTHY, JASON
1198716
ZHOU, JINGLAN
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Payments history
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).